Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
4,503,909
-
Total 13F shares
-
246,868
-
Share change
-
-15,830
-
Total reported value
-
$581,063
-
Price per share
-
$2.35
-
Number of holders
-
9
-
Value change
-
-$32,864
-
Number of buys
-
1
-
Number of sells
-
3
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q1 2019
As of 31 Mar 2019,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
246,868 shares.
The largest 9 holders included
SPHERA FUNDS MANAGEMENT LTD., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, US BANCORP \DE\, LADENBURG THALMANN FINANCIAL SERVICES INC., and Kelly Financial Services LLC.
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.